Attached files
| file | filename |
|---|---|
| EX-99.1 - EX-99.1 - PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | pacb-20150930ex9916cc486.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
September 30, 2015
Pacific Biosciences of California, Inc.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
|
|
Delaware |
|
001-34899 |
|
16-1590339 |
|
(State or other jurisdiction of incorporation) |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
1380 Willow Road
Menlo Park, California 94025
(Address of principal executive offices, including zip code)
(650) 521-8000
(Registrant’s telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2):
|
o |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
o |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
o |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
o |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 8.01. OTHER EVENTS.
On September 30, 2015, Pacific Biosciences of California, Inc. issued a press release announcing its launch of a new sequencing platform based on its Single Molecule, Real-Time (SMRT) technology. A copy of the press release containing the announcement is included as Exhibit 99.1 and is incorporated herein by reference.
|
ITEM 9.01. |
FINANCIAL STATEMENTS AND EXHIBITS. |
||||||
|
|
|
||||||
|
|
|
|
|||||
|
(d) |
|
Exhibits. |
|||||
|
|
|
|
|||||
|
99.1 |
|
Press Release dated September 30, 2015 titled “Pacific Biosciences Launches New Sequencing Platform Based on its SMRT Technology”. |
|||||
|
|
|
|
|||||
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
Pacific Biosciences of California, Inc. |
||
|
|
|
|
|
By: |
|
/s/ Susan K. Barnes |
|
|
|
Susan K. Barnes Executive Vice President, Chief Financial Officer & Principal Accounting Officer |
Date: September 30, 2015
EXHIBIT INDEX
|
Exhibit No. |
|
Description |
|
99.1 |
|
Press Release dated September 30, 2015 titled “Pacific Biosciences Launches New Sequencing Platform Based on its SMRT Technology”. |